Vivani Medical
VANI
32 hedge funds and large institutions have $3.62M invested in Vivani Medical in 2023 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 7 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 5
0.25% less ownership
Funds ownership: 7.24% → 6.99% (-0.25%)
3% less funds holding
Funds holding: 33 → 32 (-1)
14% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 7
19% less capital invested
Capital invested by funds: $4.45M → $3.62M (-$825K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$60.1K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$42.3K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$13.4K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$8.47K |
| 5 |
Jane Street
New York
|
+$1.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$172K |
| 2 |
CIBC Asset Management
Toronto,
Ontario, Canada
|
-$56.4K |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
-$16.2K |
| 4 |
HF
HRT Financial
New York
|
-$16K |
| 5 |
Millennium Management
New York
|
-$5.83K |
VANI Hedge Fund Activity: Q3 2023 in Review
32 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Vivani Medical (VANI) for Q3 2023, worth a combined $3.62M — down 19% from $4.45M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of VANI and 6 opened new positions — a net loss of 1 holder — while 5 trimmed existing stakes and 5 added.
The largest buyer was Geode Capital Management, adding an estimated $60.1K. The largest seller was BlackRock, cutting an estimated $172K.
- 32 institutional investors held Vivani Medical (VANI) as of Q3 2023, down from 33 in Q2 2023.
- Funds reported $3.62M of Vivani Medical stock for Q3 2023, down 19% quarter-over-quarter.
- 6 funds opened new Vivani Medical positions in Q3 2023 and 7 closed out, a net change of -1 holder.
- The largest Vivani Medical buyer in Q3 2023 was Geode Capital Management, an estimated $60.1K added.
- The largest Vivani Medical seller in Q3 2023 was BlackRock, an estimated $172K sold.
Based on aggregated 13F filings for Q3 2023.